Evusheld authorization paused. Ways people who are immunocompromised can protect themselves FDA has announced that Evusheld is not currently authorized for use because it is unlikely to offer protection against the COVID-19 variants that are...
Read More ›The U.S. Food and Drug Administration announced November 30, 2022 that it is pulling emergency use authorization for the monoclonal antibody treatment bebtelovimab because “it is not expected to neutralize Omicron subvariants” the...
Read More ›If you are at high risk of getting very sick from COVID-19, and test positive, treatment may be available. Get tested as soon as possible after your symptoms start.Contact your healthcare provider right away if you result is positive. Don't...
Read More ›